Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zura Bio

1.22
-0.0400-3.17%
Post-market: 1.220.00000.00%16:04 EDT
Volume:391.45K
Turnover:480.35K
Market Cap:75.49M
PE:-1.70
High:1.28
Open:1.25
Low:1.20
Close:1.26
Loading ...

Zura Bio Ltd. Files Initial Beneficial Ownership Statement for Director Daniel J. Becker

Reuters
·
30 May

Zura Bio Ltd. Files Initial Statement of Beneficial Ownership for AI Biotechnology LLC

Reuters
·
29 May

Zura Bio to Present at Jefferies Healthcare Conference

TIPRANKS
·
27 May

Zura Bio Holds Annual General Meeting of Shareholders

TIPRANKS
·
23 May

Zura Bio Ltd. Conducted Annual General Meeting of Shareholders

Reuters
·
23 May

Zura Bio’s Strategic Advancements and Promising Clinical Trials Support Buy Rating

TIPRANKS
·
23 May

BRIEF-Zura Bio Launches Global Phase 2 Tibushield Study To Evaluate Tibulizumab In Adults With Hidradenitis Suppurativa

Reuters
·
20 May

Zura Bio Launches TibuSHIELD Phase 2 Study for HS

TIPRANKS
·
20 May

Zura Bio launches global Phase 2 TibuSHIELD study evaluating tibulizumab

TIPRANKS
·
20 May

Zura Bio Ltd. Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab for Hidradenitis Suppurativa

Reuters
·
20 May

Zura Bio Launches Global Phase 2 Tibushield Study to Evaluate Tibulizumab in Adults With Hidradenitis Suppurativa

THOMSON REUTERS
·
20 May

Zura Bio Ltd - Topline Results Expected in Q3 2026

THOMSON REUTERS
·
20 May

H.C. Wainwright Remains a Hold on Zura Bio (ZURA)

TIPRANKS
·
19 May

Analysts Are Bullish on These Healthcare Stocks: Relay Therapeutics (RLAY), Zura Bio (ZURA)

TIPRANKS
·
13 May

Zura Bio Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Oppenheimer Sticks to Their Buy Rating for Zura Bio (ZURA)

TIPRANKS
·
09 May

Zura Bio price target lowered to $17 from $19 at Oppenheimer

TIPRANKS
·
09 May

Zura Bio Ltd : Leerink Partners Cuts Target Price to $11.00 From $12.00

THOMSON REUTERS
·
08 May

Zura Bio Q1 EPS $(0.19) Misses $(0.15) Estimate

Benzinga
·
08 May

Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates

THOMSON REUTERS
·
08 May